申请人:——
公开号:US20030036552A1
公开(公告)日:2003-02-20
Compounds of general formula (I), R
1
is selected from any one of phenyl, pyridinyl, thiophenyl, furanyl, imidazolyl, and triazolyl; where each R
1
phenyl ring and R
1
heteroaromatic ring may optionally and independently be further substituted by 1, 2 or 3 substituents selected from straight and branched C
1
-C
6
alkyl, NO
2
, CF
3
, C
1
-C
6
alkoxy, chloro, fluoro, bromo, and iodo. The substitutions on the phenyl ring and on the heteroaromatic ring may take place in any position on said ring systems; R
a
and R
b
is each and individually selected from any one of hydrogen, a straight and branched C
1
-C
6
alkyl, NO
2
, CF
3
, C
1
-C
6
alkoxy, chloro, fluoro, bromo, and iodo; are disclosed and claimed in the present application, as well as their pharmaceutically acceptable salts and pharmaceutical compositions comprising the novel compounds and their use in therapy, in particular in the management of pain.
通式(I)的化合物,其中R1可选择自苯基、吡啶基、噻吩基、呋喃基、咪唑基和三唑基中的任意一种;其中每个R1苯环和R1杂环环可能可选地且独立地进一步被1、2或3个取代基所取代,所述取代基可选择自直链和支链的C1-C6烷基、NO2、CF3、C1-C6烷氧基、氯、氟、溴和碘。苯环和杂环上的取代作用可以发生在所述环系统的任何位置;Ra和Rb各自选择自氢、直链和支链的C1-C6烷基、NO2、CF3、C1-C6烷氧基、氯、氟、溴和碘;本申请中披露和索要了这些化合物及其药学上可接受的盐和包含这些新化合物的制药组合物,以及它们在治疗中的用途,特别是在疼痛管理中的用途。